Senior insider sale
President and COO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$215.0K
13.89K shares
What this filing means
METZGER MICHAEL A plans to sell 13.89K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $215.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2025ACC: 0001950047-25-001520
Officer· President and COO
Since Feb 2019
13.89K
Shares to sell
$215.0K
Approx. market value
13.89K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
3/4/2025
13.89KTotal acquired13.89K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2025 | Exercise of Stock Options Cash | 13.89K | — |
| Total | 13.89K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.89K
Market value
$215.0K
3/4/2025
Total
Units
13.89K
Value
$215.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2025 | 13.89K | $215.0K | NASDAQ | Planned |
| Total | 13.89K | $215.0K | ||